A New Era of Immunotherapy in Prostate Cancer

E-ISSN： 1874-4702|9|3|217-225

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.9, Iss.3, 2016-09, pp. : 217-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate cancer immunotherapy at the dawn of the new millennium

By Salgaller M.L.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 6, 2000-06 ,pp. : 1217-1229

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy for Prostate Cancer

Current Pharmaceutical Design, Vol. 12, Iss. 7, 2006-03 ,pp. : 807-817

Bentham Science Publishers

Access to resources Recommend Favorite

Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy

Current Pharmaceutical Design, Vol. 22, Iss. 41, 2016-12 ,pp. : 6234-6250

Bentham Science Publishers

Access to resources Recommend Favorite

Second-line Treatment of Advanced Non-small Cell Lung Cancer Non-oncogene Addicted: New Treatment Algorithm in the Era of Novel Immunotherapy

Current Clinical Pharmacology, Vol. 13, Iss. 2, 2018-05 ,pp. : 76-84

Bentham Science Publishers

Access to resources Recommend Favorite

New frontiers in cell-based immunotherapy of cancer

By Milco D'Elios Mario Del Prete Gianfranco Amedei Amedeo

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 5, 2009-05 ,pp. : 623-641

Informa Healthcare

Access to resources Recommend Favorite